Grail vs MDxHealth
GRAL and MDXH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GRAL and MDXH compare
MDxHealth grew revenue faster over the last twelve months (19.8% versus 17.5% for Grail).
MDxHealth keeps more of each dollar of sales as profit, with a net margin of −31.1% compared with −244% at Grail.
Grail scores higher on the StockData Score (10 against 5 for MDxHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GRAL | MDXH |
|---|---|---|
| Size and price | ||
| Market cap | $5.2B | – |
| Share price | $115.89 | $0.144 |
| Change, 1 year | 36.7% | −96.5% |
| Change, 5 years | – | −98.6% |
| Beta (5Y) | 2.49 | 0.97 |
| Employees | 910 | 364 |
| StockData Score | ||
| Total score | 10 (better) | 5 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 1 | 1 |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 31.1× | – |
| P/B | 2.1× | – |
| FCF yield | −6.0% | – |
| Growth | ||
| Revenue growth (TTM) | 17.5% | 19.8% (better) |
| Revenue growth, 5Y average | – | 42.3% |
| Profitability | ||
| Gross margin | – | 64.5% |
| Operating margin | −347% | −13.4% (better) |
| Net margin | −244% | −31.1% (better) |
| FCF margin | −187% | −3.1% (better) |
| Return on equity | −17.3% | – |
| Return on invested capital | −27.1% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −0.6× |
| Current ratio | 8.93 (better) | 1.08 |
| Altman Z-score | 5.51 | – |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 87.6% | 32.3% |
| Held by insiders | 11.0% | – |
| Insider net buying, 12 months | −$38.0M | $991K (better) |
| Short interest, % of float | 20.1% | – |
Go deeper
- GRAL stock overview
- GRAL income statement
- GRAL valuation and score
- MDXH stock overview
- MDXH income statement
- MDXH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.